Search - tctmd.com

Displaying 821 - 840 of 15660

Sort: Relevancy | Date

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

Presenter: Seung-Jung Park, Leif Thuesen, Davide Capodanno

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Presenter: Tony Das, Koen Deloose, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty VI: Cardiac Implants

Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Presenter: Raj Makkar, Lars Sondergaard, A. Pieter Kappetein

October 31, 2016

Presentation TCT 2016

Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Elizabeth A. Leedom

October 31, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty V: Valcare

Presenter: Ted Feldman, Scott Lim, David Meerkin

October 31, 2016

Presentation TCT 2016

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Presenter: Ran Kornowski, Michel R. Le May, Natalia Pinilla-Echeverri

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington

October 31, 2016

Presentation TCT 2016

No Metallic Implants Anymore: The Case for Routine DCB!

Presenter: Tony Das, Koen Deloose, Subhash Banerjee

October 31, 2016

Presentation TCT 2016

How to Establish and Grow a CTO Program: Essentials and Pitfalls

Presenter: James C. Spratt, Simon J. Walsh, Farouc Jaffer

October 31, 2016

Presentation TCT 2016

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Jonathan M. Hill

October 31, 2016

Presentation TCT 2016

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

Presenter: Seung-Jung Park, Leif Thuesen, Marie-Claude Morice

October 31, 2016

Advertisement

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Trial #3 - The Essentials of ... the LEADERS FREE trial

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Making Sense: From Risk Scores to Triage Left Main Patients to PCI vs CABG

ABSORB II Clinical Outcomes at 3 Years

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

No Metallic Implants Anymore: The Case for Bioresorbable Scaffolds and ESPRIT I: Results

Direct Annuloplasty VI: Cardiac Implants

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Featured Lecture: Mitigating Legal Risk in Higher-Risk Coronary Procedures

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Direct Annuloplasty V: Valcare

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Pragmatic Simple Trials and Big Data: Advantages and Caveats

No Metallic Implants Anymore: The Case for Routine DCB!

How to Establish and Grow a CTO Program: Essentials and Pitfalls

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Building the CHIP Heart Team: Institutional and Network Strategies for a Successful CHIP Program

Pre-EXCEL and NOBLE: What Have We Learned From Contemporary Left Main Randomized Trials?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content